14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:DPRX
Delisted

Dipexium Pharmaceuticals Fund Predictions

$1.34
+0 (+0%)
At Close: Jan 16, 2018
Currently predicting for Tue, 7 May 2024

DPRX Predictions History

7 years ago
PeteKTF predicted that DPRX for 2017-01-30 is going $1.50 (0.00%)

7 years ago
PeteKTF predicted that DPRX for 2017-01-27 is going $1.50 (0.00%)

7 years ago
PeteKTF predicted that DPRX for 2017-01-26 is going $1.55 (3.33%)

7 years ago
PeteKTF predicted that DPRX for 2017-01-25 is going $1.50 (0.00%)

7 years ago
PeteKTF predicted that DPRX for 2017-01-24 is going $1.50 (-3.23%)

7 years ago
PeteKTF predicted that DPRX for 2017-01-23 is going $1.55 (-3.13%)

7 years ago
PeteKTF predicted that DPRX for 2017-01-20 is going $1.55 (3.33%)

7 years ago
PeteKTF predicted that DPRX for 2017-01-19 is going $1.55 (0.00%)

7 years ago
JS predicted that DPRX for 2017-01-17 is going $1.56 (-2.50%)

7 years ago
YoungBulls predicted that DPRX for 2017-01-17 is going $1.70 (6.25%)

Rank:
Click to get the best stock tips daily for free!

About Dipexium Pharmaceuticals

Dipexium Pharmaceuticals, Inc., a late stage pharmaceutical company, focuses on the development and commercialization of antibiotics in the United States. It develops Locilex (pexiganan cream 0.8%), a novel, broad spectrum, and topical antibiotic, which is in Phase 3 clinical trials for the treatment of mild infections of diabetic foot ulcers. The company was founded in 2010 and is based in New York, New York.... DPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT